Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 15,200 shares at $44.34 ($687K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $687k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.34 | 2,682 | $119K | 17.3% |
| 2 | $44.34 | 2,682 | $119K | 17.3% |
| 3 | $45.64 | 4,518 | $206K | 30.0% |
| 4 | $45.64 | 4,518 | $206K | 30.0% |
| 5 | $45.96 | 800 | $37K | 5.4% |
| Total | $45.20 avg | 15,200 |
| $687K |
| 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |
| DCPH | SELL | 2020-12-03 | $2.3M | — | Filing → |